Requiring conventional sample size calculations might be an impediment to completing translational or early clinical studies, write Peter Bacchetti and his colleagues at the University of California, San Francisco, in a Perspectives article in Science Translational Medicine. "There is little theoretical or empirical support for the conventional requirement that every study must have at least 80% power," the authors write.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.